{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:46:26Z","timestamp":1783446386511,"version":"3.55.0"},"reference-count":33,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2023,1,20]]},"abstract":"<jats:p>OBJECTIVE: To review the concordance between pathologists in the diagnosis of atypical ductal hyperplasia of the breast. METHODS: Systematic review of articles registered in the PubMed database with the terms \u201cpathologists\u201d and \u201catypical ductal hyperplasia\u201d, \u201catypical ductal hyperplasia\u201d and \u201cinterobserver variability\u201d, in Embase with \u201cinterobserver agreement in atypical ductal hyperplasia\u201d and Lilacs with the terms in Spanish \u201cpat\u00f3logos\u201d and \u201chiperplasia ductal at\u00edpica\u201d, without the use of filters, between 03\/16\/2022 and 03\/26\/2022 searching for articles that assess inter-observer agreement in the diagnosis of atypical ductal hyperplasia by using the kappa statistic. Review articles, conference proceedings, and commentaries were excluded. RESULTS: With the search terms, 507 publications were found. Of these, 491 were excluded from the screening by title and abstract. Of the full reading of the remaining articles, 6 were selected for qualitative analysis. The kappa values ranged from slight agreement, kappa = 0.17, to substantial agreement, 0.69 obtained from pathologists dedicated or experienced in breast pathology and who received a prior tutorial session to review the general criteria for atypia. CONCLUSIONS: This study reviews the reproducibility in the diagnosis of atypical ductal hyperplasia. A better concordance was obtained with a previous teaching process offered to pathologists dedicated or experienced in breast pathology.<\/jats:p>","DOI":"10.3233\/bd-220029","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T10:47:33Z","timestamp":1674211653000},"page":"545-550","source":"Crossref","is-referenced-by-count":3,"title":["Inter-observer agreement in the diagnosis of breast atypical ductal hyperplasia: A systematic review"],"prefix":"10.1177","volume":"41","author":[{"given":"Mario Arturo","family":"Gonz\u00e1lez Mari\u00f1o","sequence":"first","affiliation":[{"name":", , Universidad Nacional de Colombia, , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/BD-220029_ref1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/0100-3984.2014.0110","article-title":"Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution","volume":"49","author":"Badan","year":"2016","journal-title":"Radiol Bras"},{"key":"10.3233\/BD-220029_ref2","series-title":"WHO Classification of Tumours Series,","first-page":", 18","volume-title":"WHO Classification of Tumours Editorial Board. Breast tumours. Lyon (France): International Agency for Research on Cancer","author":"Allison","year":"2019"},{"key":"10.3233\/BD-220029_ref3","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a","article-title":"Atypical hyperplastic lesions of the female breast. A long-term follow-up study","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"key":"10.3233\/BD-220029_ref4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/1097-0142(19900201)65:3<518::aid-cncr2820650324>3.0.co;2-o","article-title":"A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast","volume":"65","author":"Tavassoli","year":"1990","journal-title":"Cancer"},{"issue":"6","key":"10.3233\/BD-220029_ref5","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1016\/j.clbc.2020.06.001","article-title":"Prospective analysis using a novel CNN algorithm to distinguish atypical ductal hyperplasia from ductal carcinoma in situ in breast","volume":"20","author":"Simukayi","year":"2020","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.3233\/BD-220029_ref6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"key":"10.3233\/BD-220029_ref7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2019190748","article-title":"Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: Systematic review and meta-analysis of 6458 lesions","volume":"294","author":"Schiaffino","year":"2020","journal-title":"Radiology"},{"key":"10.3233\/BD-220029_ref8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast \u2014 risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N Engl J Med"},{"key":"10.3233\/BD-220029_ref9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: A longitudinal cohort study","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.3233\/BD-220029_ref10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jgyn.2015.09.037","article-title":"Benign proliferative breast disease with and without atypia (in French)","volume":"44","author":"Coutant","year":"2015","journal-title":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"},{"key":"10.3233\/BD-220029_ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-010-0962-4","article-title":"Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: Which is better?","volume":"123","author":"Tse","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-220029_ref12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","article-title":"NHS breast screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)","volume":"73","author":"Pinder","year":"2018","journal-title":"Clin Radiol"},{"key":"10.3233\/BD-220029_ref13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.carj.2018.03.003","article-title":"Use of breast magnetic resonance imaging in women diagnosed with atypical ductal hyperplasia at core needle biopsy helps select women for surgical excision","volume":"69","author":"Amitai","year":"2018","journal-title":"Can Assoc Radiol J"},{"key":"10.3233\/BD-220029_ref14","volume-title":"Breast Cancer Innovations in Research and Management","author":"Cassano","year":"2017"},{"key":"10.3233\/BD-220029_ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2017.10.003","article-title":"Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients","volume":"37","author":"Latronico","year":"2018","journal-title":"Breast"},{"key":"10.3233\/BD-220029_ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.path.2021.11.001","article-title":"Error reduction and diagnostic concordance in breast pathology","volume":"15","author":"Miller","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"10.3233\/BD-220029_ref17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jama.2015.1405","article-title":"Diagnostic concordance among pathologists interpreting breast biopsy specimens","volume":"313","author":"Elmore","year":"2015","journal-title":"JAMA"},{"key":"10.3233\/BD-220029_ref18","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jmri.25694","article-title":"Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH)","volume":"46","author":"Tsuchiya","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.3233\/BD-220029_ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.3233\/BD-220029_ref20","first-page":"270","article-title":"Atypia on breast core needle biopsies: Reproducibility and significance","volume":"39","author":"Darvishian","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.3233\/BD-220029_ref21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/s0959-8049(00)00181-7","article-title":"Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European commission working group on breast screening pathology","volume":"36","author":"Elston","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.3233\/BD-220029_ref22","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/0959-8049(94)00261-3","article-title":"Consistency of histopathological reporting of breast lesions detected by screening: Findings of the UK National External Quality Assessment (EQA) scheme. UK National Coordinating Group for Breast Screening Pathology","volume":"30A","author":"Sloane","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.3233\/BD-220029_ref23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1746-1596-9-121","article-title":"Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast","volume":"9","author":"Gomes","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.3233\/BD-220029_ref24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/modpathol.2011.66","article-title":"Atypical ductal hyperplasia: interobserver and intraobserver variability","volume":"24","author":"Jain","year":"2011","journal-title":"Mod Pathol"},{"key":"10.3233\/BD-220029_ref25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2559.2008.03016.x","article-title":"Impact of immunohistochemical markers, CK5\/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions","volume":"52","author":"MacGrogan","year":"2008","journal-title":"Histopathology"},{"key":"10.3233\/BD-220029_ref26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00000478-199212000-00001","article-title":"Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria","volume":"16","author":"Schnitt","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.3233\/BD-220029_ref27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1046\/j.1524-4741.1998.440230.x","article-title":"Hyperplastic ductal and lobular lesions and carcinomas in situ of the breast: Reproducibility of current diagnostic criteria among community-and academic-based pathologists","volume":"4","author":"Palazzo","year":"1998","journal-title":"Breast J"},{"key":"10.3233\/BD-220029_ref28","volume-title":"Breast Cancer: Innovations in Research and Management","author":"Guerini-Rocco","year":"2017"},{"key":"10.3233\/BD-220029_ref29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.path.2021.11.006","article-title":"Atypical ductal hyperplasia-ductal carcinoma in situ spectrum: diagnostic considerations and treatment impact in the era of deescalation","volume":"15","author":"Sanders","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"10.3233\/BD-220029_ref30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","article-title":"NCCN guidelines (R) insights: Breast cancer, version 4.2021","volume":"19","author":"Gradishar","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.3233\/BD-220029_ref31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11912-019-0777-3","article-title":"Management of ductal carcinoma in situ (DCIS) of the breast: present approaches and future directions","volume":"21","author":"Solin","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.3233\/BD-220029_ref32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1365-2559.2010.03548.x","article-title":"Reproducibility in the diagnosis of needle core biopsies of non-palpable breast lesions: An international study using virtual slides published on the world-wide web","volume":"56","author":"Zito","year":"2010","journal-title":"Histopathology"},{"key":"10.3233\/BD-220029_ref33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiol.2019192192","article-title":"Management of breast atypical ductal hyperplasia: now and the future","volume":"294","author":"Brem","year":"2020","journal-title":"Radiology"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-220029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:32:28Z","timestamp":1777383148000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-220029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":33,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/bd-220029","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}